Zonal Characterization and Differential Trilineage Potentials of Equine Intrasynovial Deep Digital Flexor Tendon-Derived Cells
Authors: Quam Vivian G, Altmann Nadine N, Brokken Matthew T, Durgam Sushmitha
Summary
Deep digital flexor tendon injuries within the digital sheath represent a significant clinical challenge in equine practice, yet the biological properties of cells within the fibrocartilage zone—which bears compressive load and enables smooth tendon gliding—remain poorly understood compared to extrasynovial tendons. Researchers successfully isolated and characterised two distinct cell populations from equine intrasynovial DDFT tissue: fibrocartilage-derived cells (fTDC) and tendinous zone-derived cells (tTDC), comparing their growth characteristics and differentiation potential across three tissue lineages. Notably, whilst both populations expressed comparable baseline markers for tenogenic, osteogenic and chondrogenic differentiation, they displayed markedly different developmental trajectories—fTDC showed strong restriction to chondrogenic (cartilage) differentiation, whereas tTDC demonstrated osteogenic and chondrogenic capacity, with both populations showing minimal adipogenic potential. These findings suggest that cell-based therapeutic strategies might be optimised by preferentially delivering fibrocartilage-derived cells to the intrasynovial space to enhance chondrogenic repair and restore the tissue's specialised load-bearing properties. For practitioners considering regenerative medicine approaches to intrasynovial DDFT injury, this work establishes a biological rationale for cell source selection, though clinical translation will require further investigation into how these differential potentials translate to functional tendon healing and gliding capacity.
Read the full abstract on the publisher's site
Practical Takeaways
- •Cell-based therapies for intrasynovial DDFT lesions appear promising, with fibrocartilage-zone cells showing distinct chondrogenic potential suited to the mechanical demands of the intrasynovial space
- •Future therapeutic strategies should consider the zonal origin of harvested cells, as fibrocartilaginous and tendinous regions have different differentiation capacities that may influence repair outcomes
- •This foundational research suggests targeted cell therapies—particularly those promoting chondrogenic differentiation—warrant further clinical investigation for improving currently poor prognoses in intrasynovial tendon injuries
Key Findings
- •Fibrocartilaginous zone-derived cells (fTDC) restricted to chondrogenic differentiation while tendinous zone cells (tTDC) capable of osteogenic and chondrogenic differentiation
- •Both TDC subpopulations expressed CD90 and CD29 surface antigens with fibroblast-like morphology and high proliferation rates in vitro
- •fTDC and tTDC showed no significant differences in basal tenogenic, osteogenic, and chondrogenic marker expression
- •Promoting chondrogenic properties in exogenously administered cells may enhance intrasynovial tendon regeneration